The Australian Immunisation Handbook 10th Edition 2013

2.2 Administration of vaccines
• Advice is now provided on the use of vaccines in multi-dose vials.
• Advice is provided on what to do if a vaccine is inadvertently administered
via a route (e.g. intramuscular [IM] or subcutaneous [SC]) other than for
which it is recommended.
• Information is now provided on vaccinating children with congenital limb
malformation, children in spica casts, patients undergoing treatment for
breast cancer, and patients with lymphoedema.
• The section on administration of multiple vaccine injections at the same visit
now includes advice on the order in which to give sequential vaccines and
advice on simultaneous injections by two providers.
2.3 Post-vaccination
• The section on adverse events following immunisation has been enhanced
and expanded, including use of adrenaline autoinjectors for anaphylaxis
treatment and more information on reporting of adverse events following
immunisation.
• Contact details are provided for obtaining HPV vaccination history from
the National HPV Vaccination Program Register (NHVPR, or the ‘HPV
Register’).
• The section on documentation of vaccination has been expanded to include
updated details for reporting to the ACIR, and information on the National
HPV Vaccination Program Register and other registers.
Part 3 Vaccination for special risk groups
3.1 Vaccination for Aboriginal and Torres Strait Islander people
• Information on the burden of influenza in Indigenous children, and the
rationale for vaccination of those, especially ≥6 months to